4.8 Article

Butyrophilin 2A1 is essential for phosphoantigen reactivity by γδ T cells

期刊

SCIENCE
卷 367, 期 6478, 页码 642-+

出版社

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.aay5516

关键词

-

资金

  1. Cancer Council of Victoria [1126866]
  2. Australian Research Council (ARC) [CE140100011, DP170102471]
  3. National Health and Medical Research Council of Australia (NHMRC) [1165467, 1113293]
  4. Victorian Government, Australia
  5. ARC Future Fellowship [FT140100278]
  6. Department of Health and Human Services acting through the Victorian Cancer Agency
  7. NHMRC Senior Principal Research Fellowship [1117766]
  8. Deutsche Forschungsgemeinschaft [GRK2168]
  9. University of Melbourne through the International Research and Research Training Fund
  10. NHMRC Principal Research Fellowship [1154502]
  11. ARC Discovery Early Career Researcher Award [DE170100575]
  12. AMP Tomorrow Fund
  13. National Health and Medical Research Council of Australia [1154502, 1165467] Funding Source: NHMRC
  14. Australian Research Council [DE170100575] Funding Source: Australian Research Council

向作者/读者索取更多资源

Gamma delta (gamma delta) T cells are essential to protective immunity. In humans, most gamma delta T cells express V gamma 9V delta 2(+) T cell receptors (TCRs) that respond to phosphoantigens (pAgs) produced by cellular pathogens and overexpressed by cancers. However, the molecular targets recognized by these gamma delta TCRs are unknown. Here, we identify butyrophilin 2A1 (BTN2A1) as a key ligand that binds to the V gamma 9(+) TCR gamma chain. BTN2A1 associates with another butyrophilin, BTN3A1, and these act together to initiate responses to pAg. Furthermore, binding of a second ligand, possibly BTN3A1, to a separate TCR domain incorporating V delta 2 is also required. This distinctive mode of Ag-dependent T cell activation advances our understanding of diseases involving pAg recognition and creates opportunities for the development of gamma delta T cell-based immunotherapies.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据